Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.
Dou Y, Xu K, Deng YQ, Jia Z, Lan J, Xu X, Zhang G, Cao T, Liu P, Wang X, Wang X, Xu L, Du P, Qin CF, Liu H, Li Y, Wu G, Wang K, Lu B.
Dou Y, et al. Among authors: du p.
Antib Ther. 2023 Feb 17;6(2):76-86. doi: 10.1093/abt/tbad002. eCollection 2023 Apr.
Antib Ther. 2023.
PMID: 37077472
Free PMC article.